bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.01.646635

Primary envelopment of Kaposi's sarcoma-associated herpesvirus at the nucleoplasmic reticulum

Abstract

Herpesvirus egress begins with primary envelopment of newly assembled capsids at the inner nuclear membrane (INM) facilitated by a viral nuclear egress complex (NEC). Primary envelopment has been observed at the peripheral INM as well as at structures known as nuclear infoldings. Nuclear infoldings resulting from invaginations of the INM are known as Type-I nucleoplasmic reticulum (NR), whereas infoldings of both INM and outer nuclear membrane (ONM) are known as Type-II NR. Here, we report that Kaposis sarcoma-associated herpesvirus (KSHV) reactivation from latency and lytic cycle progression correlates with increases in both types of NR invaginations, but primary envelopment was restricted to Type-I NR and the peripheral INM. Over a time-course of infection, DNA-containing KSHV C-capsids were frequently observed budding into nuclear infoldings contiguous with the INM and sparsely decorated with nuclear lamina, characteristic of Type-I NR. These Type-I NR structures co-localized with puncta containing CTP:phosphocholine cytidylyltransferase (CCT), the enzyme that catalyzes the rate-limiting step in phosphatidylcholine (PtdCho) synthesis, and drives de novo membrane biogenesis and membrane curvature required for NR expansion; this may provide sufficient Type-I NR to match requirements for KSHV nuclear egress. The selective utilization of the Type-I NR for primary envelopment despite the concurrent expansion of the Type-II NR suggests a mechanism to target C-capsids into the Type-I NR. We also observed accumulation of de-enveloped KSHV C-capsids in 2nd order nuclear infoldings, suggesting that primary envelopment and de-envelopment can occur not only at the nuclear periphery, but also at the Type-I NR. ImportanceHerpesvirus capsids assemble in the cell nucleus but are too large to exit via nuclear pores. Instead, they invade the inner nuclear membrane and acquire a provisional lipid envelope that is quickly shed through fusion with the outer nuclear membrane, a neat trick that delivers the capsid to the cytoplasm for subsequent steps in assembly and egress. Dynamic rearrangements of the nuclear membrane include invaginations that plumb the depths of the nucleus to facilitate cargo trafficking. Here, we demonstrate that during Kaposis sarcoma-associated herpesvirus (KSHV) replication, nuclear membrane infolding and expansion events increase, coinciding with recruitment of a host enzyme required for phosphatidyl choline synthesis to these sites. We observed an abundance of KSHV capsids at infoldings of the inner nuclear membrane, as well as free capsids in the interior of second order infoldings suggestive of de-envelopment events occurring prior to infold retraction. This complements a more well-established mechanism of KSHV egress at the nuclear periphery, and indeed, we observed concomitant egress of KSHV capsids via both mechanisms from the same nucleus. Similar observations for other herpesviruses by other groups suggests that this versatility in nuclear egress mechanisms is conserved.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wilson, A., Ridgway, N., McCormick, C.. 2025-04-02. Primary envelopment of Kaposi's sarcoma-associated herpesvirus at the nucleoplasmic reticulum. https://doi.org/10.1101/2025.04.01.646635

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗